Abstract:Matthew T Scharf Sleep Center, Division of Pulmonary and Critical Care, Department of Medicine and Department of Neurology, Rutgers- Robert Wood Johnson Medical School, New Brunswick, NJ, USA Correspondence: Matthew T Scharf, Division of Pulmonary and Critical Care Medicine, Rutgers-Robert Wood Johnson Medical School, MEB 535, 1 Robert Wood Johnson Place, New Brunswick, NJ, 08901, USA, Tel +1 732 235-7840, Fax +1 732 235-7944, Email The Epworth sleepiness scale (ESS) is a commonly used questionnaire to evaluate patients for excessive daytime sleepiness (EDS). The ESS has been validated as a measure of EDS, but a number of studies have shown more test–retest variability in clinical settings compared to the original validation study. This observation of higher-than-expected test–retest variability has called into question the utility of the ESS as a clinical tool to assess EDS. The purpose of this review article is to summarize how studies of test–retest variability in clinical populations compare to the original validation study of Johns and to highlight where they differ. Furthermore, use of the ESS as a continuous variable (with no specified cutoff value) versus a categorical variable (normal versus high) is described. These observations are put into a clinical context by comparing the test–retest variability observed on the ESS with that of the multiple sleep latency test (MSLT). Finally, how contributors to ESS scores differ within certain subpopulations is described. The ESS remains an important tool to measure EDS in patient populations, but an awareness of its limitations needs to be considered. Keywords: excessive daytime sleepiness, EDS, test-retest reliability, Cohen's kappa, multiple sleep latency test Excessive daytime sleepiness (EDS) is a common complaint for which patients are referred to sleep clinic. EDS is important not only because it is a dysphoric feeling for patients and is associated with impairments in functioning such as an increased risk for motor vehicle crashes 1 and occupational injury, 2 but also because it is associated with increased mortality. 3,4 In one poignant study that assessed the contribution of EDS and obstructive sleep apnea (OSA) to mortality in elderly patients, those with obstructive sleep apnea (OSA) and EDS had increased mortality; those with either OSA or EDS alone did not have increased mortality. 5 Similarly, in patients with moderate-severe OSA, the risk of major adverse cardiac events was higher in those with EDS. 6 These studies suggest that EDS may be a critical component in linking certain diseases, such as OSA, to deleterious outcomes including mortality. In fact, exclusion of patients with EDS in certain randomized controlled trials of OSA treatment has cast doubts on the generalizability of the findings. 7 However, despite the fact that EDS is clearly important, there is no consensus on the optimal way to assess EDS. There are objective measures such as the multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT), and self-reported measures including single-item questions, 3,4 two-item questionnaires, 8,9 and more comprehensive validated questionnaires including the Epworth Sleepiness Scale (ESS). 10 The ESS has been used extensively in clinical and research settings and will be the focus of this review. The ESS was developed by Murray Johns at Epworth Hospital in Australia and was first reported in 1991. 10 The ESS was designed to be a simple test to administer and interpret. It asked patients to rate their likelihood of "dozing" in eight different scenarios with a minimum score of 0 indicating "would never doze" to a maximum score of 3 indicating a "high chance of dozing." The total score can range from a minimum of 0 indicating a low level of sleepiness to a maximum of 24 indicating a very high level of sleepiness. Patients were asked to refer to "your usual way of life in recent times" rather than how they are feeling at the moment. In the original validation study, ESS scores were higher in patients with OSA, narcolepsy, and idiopathic hypersomnia compared to control subjects and were lower in patients with insomnia. Furthermore, the ESS score was associated with OSA severity such that patients with worse OSA had higher ESS scores. In a small subset of patients for whom MSLTs were available, the ESS score was inversely correlated with mean sleep latency. 10 The associations between the ESS and OSA and the ESS and the MSLT were further detailed in subsequent studies by Johns. 11,12 One important consideration with any measure is test–retest reliability. In other words, in the absence of an intervention, one would expect the score to be stable over time. Johns showed that in healthy medical students, E -Abstract Truncated-

Psychometric Scales Measuring Hypersomnolence

Evaluation of hypersomnolence: From symptoms to diagnosis, a multidimensional approach

Evaluation of psychometric properties of patient-reported outcome measures frequently used in narcolepsy randomized controlled trials: a systematic review

French consensus. Hypersomnolence: Evaluation and diagnosis

A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders

0853 The Importance of Actigraphy in Assessment of Hypersomnia in Children

Measuring Subjective Sleep Quality: A Review

Objective evaluation of excessive daytime sleepiness

Symptom Measures in Pediatric Narcolepsy Patients: a Review

Major depressive disorder with hypersomnolence complaint: A comparison study with non-depressed individuals examining objective biomarkers

Idiopathic Hypersomnia: Historical Account, Critical Review of Current Tests and Criteria, Diagnostic Evaluation in the Absence of Biological Markers and Robust Electrophysiological Diagnostic Criteria

Clozapine and objective assessment of hypersomnolence in patients with schizophrenia: a systematic review

Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea

Diagnosing and treating hypersomnolence in depression

Evaluation of the measurement properties of the Epworth sleepiness scale: A systematic review

Reliability and Efficacy of the Epworth Sleepiness Scale: Is There Still a Place for It?

The Perception and Attention Functions test battery as a measure of neurocognitive impairment in patients with suspected central disorders of hypersomnolence

Multiple Sleep Latency Test/Maintenance of Wakefulness Test and Central Hypersomnias: Evolving Diagnostic and Therapeutic Approaches

Fatigued but not sleepy? An empirical investigation of the differentiation between fatigue and sleepiness in sleep disorder patients in a cross-sectional study

1026 Validation of the Situational Sleepiness Scale

Optimal Questions for Sleep in Epidemiological Studies: Comparisons of Subjective and Objective Measures in Laboratory and Field Studies